Myllia Biotechnology
Pre-clinicalAt Myllia, we perform functional genomics at scale in advanced cellular models to map the impact of thousands of genetic perturbations at single-cell resolution - a new paradigm to nominate the best possible targets for your drug discovery campaign.
Founded
2019
Focus
DiagnosticsGenetics & Genomics
About
At Myllia, we perform functional genomics at scale in advanced cellular models to map the impact of thousands of genetic perturbations at single-cell resolution - a new paradigm to nominate the best possible targets for your drug discovery campaign.
Funding History
2Total raised: $3.1M
Grant$600KFFGMar 15, 2022
Seed$2.5Maws GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationVienna, Austria
StagePre-clinical
Contact
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile